158 related articles for article (PubMed ID: 36982853)
21. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
22. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
23. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
24. Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A
Hong HJ; Nam GS; Nam KS
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569361
[TBL] [Abstract][Full Text] [Related]
25. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
Packham MA; Kinlough-Rathbone RL; Mustard JF
Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
[TBL] [Abstract][Full Text] [Related]
26. Ask1 regulates murine platelet granule secretion, thromboxane A
Naik MU; Patel P; Derstine R; Turaga R; Chen X; Golla K; Neeves KB; Ichijo H; Naik UP
Blood; 2017 Mar; 129(9):1197-1209. PubMed ID: 28028021
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets.
Kramer RM; Roberts EF; Manetta JV; Hyslop PA; Jakubowski JA
J Biol Chem; 1993 Dec; 268(35):26796-804. PubMed ID: 8253817
[TBL] [Abstract][Full Text] [Related]
28. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
[TBL] [Abstract][Full Text] [Related]
29. Thrombopoietin increases platelet sensitivity to alpha-thrombin via activation of the ERK2-cPLA2 pathway.
van Willigen G; Gorter G; Akkerman JW
Thromb Haemost; 2000 Apr; 83(4):610-6. PubMed ID: 10780326
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of CK2 inhibitor (E)-3-(2,3,4,5-tetrabromophenyl)acrylic acid (TBCA) in regulation of platelet function.
Ryu SY; Kim S
Eur J Pharmacol; 2013 Nov; 720(1-3):391-400. PubMed ID: 24140231
[TBL] [Abstract][Full Text] [Related]
31. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.
Garcia A; Kim S; Bhavaraju K; Schoenwaelder SM; Kunapuli SP
Biochem J; 2010 Jul; 429(2):369-77. PubMed ID: 20441566
[TBL] [Abstract][Full Text] [Related]
32. Protein disulfide isomerase-A1 regulates intraplatelet reactive oxygen species-thromboxane A
Przyborowski K; Kurpinska A; Wojkowska D; Kaczara P; Suraj-Prazmowska J; Karolczak K; Malinowska A; Pelesz A; Kij A; Kalvins I; Watala C; Chlopicki S
J Thromb Haemost; 2022 Jan; 20(1):157-169. PubMed ID: 34592041
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets.
Moscardó A; Vallés J; Piñón M; Aznar J; Martínez-Sales V; Santos MT
Platelets; 2006 Sep; 17(6):405-15. PubMed ID: 16973502
[TBL] [Abstract][Full Text] [Related]
34. Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin.
Cho MJ; Pestina TI; Steward SA; Lowell CA; Jackson CW; Gartner TK
Blood; 2002 Apr; 99(7):2442-7. PubMed ID: 11895777
[TBL] [Abstract][Full Text] [Related]
35. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
36. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
Hanasaki K; Nakano T; Arita H
Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological Actions of 5-Hydroxyindolin-2 on Modulation of Platelet Functions and Thrombus Formation via Thromboxane A
Kwon HW; Kim SD; Rhee MH; Shin JH
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498873
[TBL] [Abstract][Full Text] [Related]
38. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
[TBL] [Abstract][Full Text] [Related]
39. Carrageenan-induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes.
Vargaftig BB; Fouque F; Chignard M; Dumarey C
J Pharm Pharmacol; 1980 Nov; 32(11):740-5. PubMed ID: 6110720
[TBL] [Abstract][Full Text] [Related]
40. The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation.
Cho MJ; Liu J; Pestina TI; Steward SA; Thomas DW; Coffman TM; Wang D; Jackson CW; Gartner TK
Blood; 2003 Apr; 101(7):2646-51. PubMed ID: 12446460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
